Our Commitment to Social Responsibility
With the same passion we have for developing transformative therapies for people living with serious diseases, we are committing ourselves to making a difference for all our stakeholders – our patients, our employees, our communities and our earth. Our approach and efforts to corporate responsibility continue to expand as we grow and the world changes around us.
Our Committee
In 2022, we established an environmental, social and governance (ESG) committee to provide oversight and to ensure that we develop the right programs and policies across our organization. This Committee, which is chaired by CEO Matt Kapusta and comprises both executives and staff across our organization, is key to advancing our corporate responsibility strategy.
The Committee is currently focused on the following priorities:
Community Outreach
Supporting the patients whom we serve and the communities in which we work
Diversity, Equity & Inclusion
Fostering an inclusive culture and diverse workforce
Employee Wellness & Engagement
Investing in our employees’ health, growth and success
Environmental Impact
Improving the sustainability of our planet
Our Report
In our corporate responsibility report — first published in 2023 and updated in 2024 — we aim to show how our work is favorably impacting all our stakeholders. We are just beginning with our efforts on corporate responsibility reporting, and as such, we expect to continuously improve transparency, establish targets and track our performance.
2023 Corporate Responsibility Report
